+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 231 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report 2026 - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 203 Pages
  • Global
From
Primary Immunodeficiency Disorders - Global Strategic Business Report - Product Thumbnail Image

Primary Immunodeficiency Disorders - Global Strategic Business Report

  • Report
  • November 2026
  • 280 Pages
  • Global
From
Dermatological Drugs - Global Strategic Business Report - Product Thumbnail Image

Dermatological Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 422 Pages
  • Global
From
SGLT2 - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

SGLT2 - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • April 2026
  • 100 Pages
  • Global
From
Tetanus Toxoid Vaccine - Global Strategic Business Report - Product Thumbnail Image

Tetanus Toxoid Vaccine - Global Strategic Business Report

  • Report
  • November 2026
  • 265 Pages
  • Global
From
Polio Vaccines - Global Strategic Business Report - Product Thumbnail Image

Polio Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 277 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 468 Pages
  • Global
From
Toxoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Human Embryonic Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Human Embryonic Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 110 Pages
  • Global
From
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 490 Pages
  • Global
From
DNA Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

DNA Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 171 Pages
  • Global
From
Live Attenuated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Live Attenuated Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 563 Pages
  • Global
From
Cholera Vaccines - Global Strategic Business Report - Product Thumbnail Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 367 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Treatment Market in Apac 2026-2030 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Treatment Market in Apac 2026-2030

  • Report
  • January 2026
  • 192 Pages
  • Asia Pacific
From
Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 307 Pages
  • Global
From
Interstitial Cystitis Market Report 2026 - Product Thumbnail Image

Interstitial Cystitis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2025 - Product Thumbnail Image

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032

  • Report
  • August 2022
  • 152 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2026

  • Report
  • May 2026
  • 550 Pages
  • Global
From
Loading Indicator